Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer.

With this decision, Optune Pax becomes the first new FDA-approved treatment for locally advanced pancreatic cancer in decades ...

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer. With an overall survival rate of around 13%, it’s also one of the deadliest cancers. One reason for this is that ...

As women, we don't tend to give pancreatic cancer much thought. Instances of the disease are pretty rare overall, with pancreatic cancer only accounting for 3% of all cancers in the United States, per ...

CURE spoke with Dr. Rosario Ligestri and Dr. Anna Berkenblit about the rising rate of pancreatic cancer in relatively younger adults. Following the Oct. 14, 2025 death of R&B singer D’Angelo from ...

Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer. Notoriously aggressive and difficult to treat, pancreatic cancer is rarely ...

Add Yahoo as a preferred source to see more of our stories on Google. While every cancer is daunting, pancreatic cancer is particularly alarming because of its notoriously low cure rate. There’s no ...